The analogs of nitrogen-based heterocycles occupy an exclusive position as a valuable source of therapeutic agents in medicinal chemistry. More than 75% of drugs approved by the FDA and currently available in the market are nitrogen-containing heterocyclic moieties. In the forthcoming decade, a much greater share of new nitrogen-based pharmaceuticals is anticipated. Many new nitrogen-based heterocycles have been designed. The number of novel N-heterocyclic moieties with significant physiological properties and promising applications in medicinal chemistry is ever-growing. In this review, we consolidate the recent advances on novel nitrogen-containing heterocycles and their distinct biological activities, reported over the past one year (2019 to early 2020). This review highlights the trends in the use of nitrogen-based moieties in drug design and the development of different potent and competent candidates against various diseases.
1 May 2018 in European Journal of Medicinal Chemistry
Among the bioactive heterocyclic frameworks, nitrogen containing multisubstituted imidazoles are versatile building blocks of many naturally occurring products. Imidazoles possess wide range of biological properties including anticancer, anti-inflammatory, antimicrobial, and antihypertensive activities with potential applications in other sectors. Multicomponent reactions in combination with heterogeneous catalysts and nanocomposites have contributed significantly to organic synthesis in general and imidazoles, in particular with high functional group tolerance. Owing to their tunable properties, lower operational cost, thermal stability, recyclability, and easily separation from products, heterogeneous catalysts and nanocomposites are integral part of numerous pharmaceutical, agrochemical, and industrial processes. There has been increased focus on the development of green and sustainable catalytic procedures for the building of novel and biologically potent imidazole conjugates. This article emphasizes the recent advances in recyclable catalysts and protocols, and their merits for the synthesis of diverse multisubstituted imidazole conjugates by one-pot reaction approach and the catalyst and reactant interactions. Graphical Abstract